Drug Shortage Report for AURO-TELMISARTAN
Report ID | 99162 |
Drug Identification Number | 02453568 |
Brand name | AURO-TELMISARTAN |
Common or Proper name | Telmisartan |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-09-30 |
Estimated end date | 2023-11-30 |
Actual end date | 2023-11-28 |
Shortage status | Resolved |
Updated date | 2023-11-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-18 | English | Compare |
v2 | 2019-11-18 | French | Compare |
v3 | 2019-11-19 | English | Compare |
v4 | 2020-09-29 | English | Compare |
v5 | 2020-09-29 | French | Compare |
v6 | 2021-01-07 | English | Compare |
v7 | 2021-01-07 | French | Compare |
v8 | 2021-02-03 | English | Compare |
v9 | 2021-02-03 | French | Compare |
v10 | 2021-04-30 | English | Compare |
v11 | 2021-04-30 | French | Compare |
v12 | 2021-07-27 | English | Compare |
v13 | 2021-07-27 | French | Compare |
v14 | 2021-10-29 | English | Compare |
v15 | 2021-10-29 | French | Compare |
v16 | 2023-07-24 | English | Compare |
v17 | 2023-07-24 | French | Compare |
v18 | 2023-08-29 | English | Compare |
v19 | 2023-08-29 | French | Compare |
v20 | 2023-09-13 | English | Compare |